HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach
Lebrec, H., Brennan, F.R., Haggerty, H., Herzyk, D., Kamperschroer, C., Maier, C.C., Ponce, R., Preston, B.D., Weinstock, D., Mellon, R.D.Volume:
75
Language:
english
Journal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2015.12.018
Date:
March, 2016
File:
PDF, 785 KB
english, 2016